Sales of cancer and rheumatoid arthritis treatment Rituxan, co-marketed with Roche Holding AG (RHHBY), dropped 15% to $257 million in the US, as royalties ...
... Commission approved Orencia in combination with methotrexate for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis, ...
BR) rheumatoid arthritis drug Cimzia, after the Belgian drugmaker agreed to provide it for free during the first 12 weeks. The National Institute for Health ...
The draft decision by Nice comes just weeks after the organisation turned down a rheumatoid arthritis drug even though the medication is available to NHS ...
A powerful arthritis drug that may be barred from most NHS patients has been given the green light in Scotland. Tocilizumab has provisionally been judged ...
... rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease and transplant rejection. Lycera is developing drug candidates that target two ...
Bohai's medicines address common health problems such as rheumatism, rheumatoid arthritis, respiratory diseases, viral infections, gynecological diseases ...
Email this story
